AVR 1.29% $17.97 anteris technologies ltd

Admedus would be a good investment if the fundamental strategy...

  1. 1,857 Posts.
    lightbulb Created with Sketch. 50
    Admedus would be a good investment if the fundamental strategy looked like being viable, however ...
    Strategy to date has been to develop, produce & market their suite of surgical products.
    The first, and even in combination with the 2nd, doesn't equal viable.

    So who cares what they've developed? Who cares what volume they can produce? On what basis can we anticipate a meaningful slice of their target market will buy the product?

    Unless of course Admedus changes tack, and sells their invention to a player in the medical-surgical space who can sell the product.
    But nothing I've seen yet suggests any such change in tack is contemplated.

    I'm sitting on a few AHZO oppies. Bottom drawer.

    Regards,
    P
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.